The US health care system’s transition to value-based care (VBC) holds important implications for medical innovation. New value-based payment models shift financial risk from health plans to providers and other stakeholders, changing how they assess and adopt innovation.
Performance measures and financial incentives in these payment models may encourage the use of therapies or technologies that save money in the short term or improve care as defined by a fairly narrow set of quality measures, potentially limiting patient access to innovation.
For more details, download White Paper here:
Delivering medical innovation in a value-based world Only registered and logged in users can download this file.